查詢結果分析
來源資料
相關文獻
- Post-Renal Transplant Erythrocytosis
- 小兒的腎臟移植
- 鐵劑之補充可加強早產兒使用基因重組人類紅血球生成素之作用
- Renal Transplantation at a Medical Center in Taiwan
- 處方評估及用藥檢討:腎移植後急性排斥之治療
- 紅血球生成素1998
- 腎移植者生活品質之研究
- Porphyromonas Gingivalis Bacteremia and Subhepatic Abscess after Renal Transplantation: A Case Report
- Malignancy Following Renal Transplantation
- The Effect of Recombinant Human Erythropoietin in Treating the Anemia of Prematurity
頁籤選單縮合
題 名 | Post-Renal Transplant Erythrocytosis=腎移植後紅血球過多症 |
---|---|
作 者 | 簡宏志; 黃秋錦; 黃正誼; 朱聖賢; 賴明坤; | 書刊名 | 長庚醫學 |
卷 期 | 19:3 1996.09[民85.09] |
頁 次 | 頁235-240 |
分類號 | 416.273 |
關鍵詞 | 腎臟移植; 紅血球過多症; 紅血球生成素; Renal transplantation; Erythrocytosis; Erythropoietin; |
語 文 | 英文(English) |
中文摘要 | 紅血球過多症是腎移植後相當常見的現象。它除了有特殊的臨床特徵外也會增加血栓性栓塞的機會。因此我們對腎栘植病人併發紅血球過多症者,做了臨床特徵及危險因素之分析。 在175位腎移植病人中有17位(9.7%)發生紅血球多症,也就是血容比大於或等於50%,分別是14位男性,3位女性。13位接受屍腎移值,4位接受活腎移植。其中7位有上升的紅血球質量(RBC mass)為絕對性紅血球過多症(true erythrocytosis),10位有正常的紅血球質量為相對性紅血球過多症(relative erythrocytosis)。6位病人發生腎囊腫,它的發生率是有意義地高於非紅血球過多症病人。 在紅血球過多症及非紅血球過多症兩組病人當中,有類似的年紀、性別、血清白蛋白值、血清肌氨酸肝值,以及肝功能異常率、高血壓發生率。所有發生紅血球過多症的病人都接受環孢靈治療,而另外14位沒有接受環孢靈治療病人中,沒人發生紅血球過多症(p > 0.05)。只有一個絕對性紅血球過多症病人血清的紅血球生成素(erythropoeitin)值上升。所有病人在追蹤時間內沒有血栓性栓塞發生。 結論:(1)紅血球過多症在我們腎移植病人的發生率為9.7%;(2)紅血球過多症病人有較高腎囊腫發生率;(3)大部分紅血球過多症病人有正常血清紅血球生成素值;(4)在我們腎移植病人中,沒有血栓性栓塞之發生。 |
英文摘要 | Erythrocytosis is a relatively common phenomenon following renal transplantation. It is not only associated with some special clinical conditions, but also increases the risk of thromboembolism. We therefore studied the clinical manifestations and possible risk factors of erythrocytosis in our renal-transplant patients. Study of 175 patients showed that erythrocytosis, defined as Hct [] 50%, was found in 17 patients (9.7%), 14 males and 3 females. Among these 17 patients, 13 received cadaveric grafts and the other 4 living-related grafts. True erythrocytosis, defined as erythrocytosis with elevated red blood cell (RBC) mass, was found in 7 patients. Relative erythrocytosis, defined as erythrocytosis with normal RBC mass, was found in the other 10 patients. Six patients developed acquired renal cysts of the native or graft kidneys during the post transplant period. The incidence of acquired renal cysts in the erythrocytosis group was significantly higher than that in the non-erythrocytosis group. The clinical and demographic characteristics were similar in terms of age, gender, serum albumin, and serum creatinine in the erythrocytosis and non-erythrocytosis groups. The incidences of abnormal liver function, and hypertension were similar between the 2 groups. Seventeen of the 161 patients (10.6%) receiving cyclosporine regimen developed erythrocytosis, but none of the 14 patients receiving non-cyclosporine regimen developed erythrocytosis (p > 0.05). Only one patient with true erythrocytosis had an elevated serum erythropoietin (EPO) level adn no thromboembolic complications occurred in the erythrocytosis group. We conclude that: (1) the incidence of erythrocytosis in our transplant patients was 9.7%; (2) a higher incidence of acquired renal cysts was found in the erythrocytosis group; (3) most of the patients with erythrocytosis and a normal serum EPO level; (4) no thromboembolic complications occurred in our patients. |
本系統中英文摘要資訊取自各篇刊載內容。